News + Filings Transactions Holdings
|
Bain Capital Life Sciences Investors, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Nuvalent, Inc.
| NUVL | Common | 3,577,267 | 149,253 | 150,853,349,000 | 150,786,708,000 | 15.54 | 6.30 |
Hist
| 06/30/2023 |
NewAmsterdam Pharma Co N.V.
| NAMS | Common | 10,473,913 | 10,473,913 | 124,534,826,000 | 124,534,826,000 | 12.83 | 12.84 |
Hist
| 06/30/2023 |
SpringWorks Therapeutics, Inc.
| SWTX | Common | 3,081,307 | -1,750,000 | 80,791,870,000 | 80,654,033,000 | 8.32 | 4.93 |
Hist
| 06/30/2023 |
Pharvaris N.V.
| PHVS | Common | 4,868,784 | 1,688,183 | 73,713,390,000 | 73,688,995,000 | 7.59 | 14.40 |
Hist
| 06/30/2023 |
Disc Medicine, Inc.
| IRON | Common | 1,332,548 | 1,332,548 | 59,165,131,000 | 59,165,131,000 | 6.09 | 6.73 |
Hist
| 06/30/2023 |
Crinetics Pharmaceuticals, Inc.
| CRNX | Common | 2,305,558 | 0 | 41,546,155,000 | 41,500,874,000 | 4.28 | 4.27 |
Hist
| 06/30/2023 |
Savara Inc
| SVRA | Common | 11,622,598 | 0 | 37,134,201,000 | 37,116,186,000 | 3.82 | 10.19 |
Hist
| 06/30/2023 |
Aclaris Therapeutics, Inc.
| ACRS | COM | 3,400,000 | 3,400,000 | 35,258,000,000 | 35,258,000,000 | 3.63 | 4.81 |
Hist
| 06/30/2023 |
Natera, Inc.
| NTRA | COMMON | 700,197 | 700,197 | 34,071,586,000 | 34,071,586,000 | 3.51 | |
Hist
| 06/30/2023 |
DYNAVAX TECHNOLOGIES CORP
| DVAX | Common | 2,415,000 | -3,000,000 | 31,201,800,000 | 31,145,267,000 | 3.21 | 1.89 |
Hist
| 06/30/2023 |
X4 Pharmaceuticals, Inc
| XFOR | Common | 15,960,588 | 9,571,152 | 30,963,541,000 | 30,952,615,000 | 3.19 | |
Hist
| 06/30/2023 |
Arcutis Biotherapeutics, Inc.
| ARQT | Common | 3,000,000 | 0 | 28,590,000,000 | 28,532,670,000 | 2.94 | 4.88 |
Hist
| 06/30/2023 |
Mersana Therapeutics, Inc.
| MRSN | Common | 8,663,673 | 0 | 28,503,484,000 | 28,444,918,000 | 2.94 | 7.57 |
Hist
| 06/30/2023 |
CymaBay Therapeutics, Inc.
| CBAY | Common | 2,500,000 | 2,500,000 | 27,375,000,000 | 27,375,000,000 | 2.82 | 2.57 |
Hist
| 06/30/2023 |
Cabaletta Bio, Inc.
| CABA | Common | 2,000,000 | 2,000,000 | 25,820,000,000 | 25,820,000,000 | 2.66 | 6.38 |
Hist
| 06/30/2023 |
Annexon, Inc.
| ANNX | Common | 5,701,926 | 2,100,000 | 20,070,780,000 | 20,048,520,000 | 2.07 | 7.58 |
Hist
| 06/30/2023 |
EQRx, Inc.
| EQRX | Common | 10,003,573 | 0 | 18,606,646,000 | 18,557,128,000 | 1.92 | 2.05 |
Hist
| 06/30/2023 |
Nurix Therapeutics, Inc.
| NRIX | Common | 1,822,883 | 0 | 18,210,601,000 | 18,186,849,000 | 1.88 | 3.78 |
Hist
| 06/30/2023 |
Solid Biosciences Inc.
| SLDB | COM NEW | 3,130,422 | 3,130,422 | 16,403,411,000 | 16,403,411,000 | 1.69 | 15.97 |
Hist
| 06/30/2023 |
MARINUS PHARMACEUTICALS, INC.
| MRNS | Common | 1,431,058 | 0 | 15,541,290,000 | 15,531,773,000 | 1.60 | 2.83 |
Hist
| 06/30/2023 |
2seventy bio, Inc.
| TSVT | Common | 1,408,901 | 0 | 14,258,078,000 | 14,237,578,000 | 1.47 | 2.81 |
Hist
| 06/30/2023 |
Atea Pharmaceuticals, Inc.
| AVIR | Common | 2,485,638 | 0 | 9,296,286,000 | 9,282,143,000 | 0.96 | 2.98 |
Hist
| 06/30/2023 |
RAPID MICRO BIOSYSTEMS, INC.
| RPID | COM | 8,434,560 | 0 | 8,434,560,000 | 8,407,316,000 | 0.87 | 19.93 |
Hist
| 06/30/2023 |
Nautilus Biotechnology, Inc.
| NAUT | Common | 2,000,000 | 0 | 7,740,000,000 | 7,735,760,000 | 0.80 | 1.60 |
Hist
| 06/30/2023 |
Xilio Therapeutics, Inc.
| XLO | Common | 2,805,413 | 0 | 7,350,182,000 | 7,342,018,000 | 0.76 | 10.21 |
Hist
| 06/30/2023 |
Syros Pharmaceuticals, Inc.
| SYRS | Common | 2,124,694 | 1,042,290 | 6,692,786,000 | 6,685,815,000 | 0.69 | 10.32 |
Hist
| 06/30/2023 |
Tango Therapeutics, Inc.
| TNGX | Common | 1,921,790 | 0 | 6,380,343,000 | 6,373,386,000 | 0.66 | 2.17 |
Hist
| 06/30/2023 |
C4 Therapeutics, Inc.
| CCCC | Common | 1,642,210 | 0 | 4,516,078,000 | 4,501,676,000 | 0.47 | 3.35 |
Hist
| 06/30/2023 |
Third Harmonic Bio, Inc.
| THRD | Common | 640,631 | -1,639,451 | 3,081,435,000 | 3,038,182,000 | 0.32 | 1.59 |
Hist
| 06/30/2023 |
Cara Therapeutics, Inc.
| CARA | Common | 934,898 | -1,712,575 | 2,645,761,000 | 2,620,981,000 | 0.27 | 1.73 |
Hist
| 06/30/2023 |
Invivyd, Inc.
| ADGI | Common | 1,937,207 | 0 | 2,034,067,000 | 2,028,004,000 | 0.21 | 1.77 |
Hist
| 06/30/2023 |
Aeglea BioTherapeutics, Inc.
| AGLE | COM | 0 | -5,347,689 | 0 | -2,813,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Solid Biosciences Inc.
| SLDB | Common | 0 | -7,929,918 | 0 | -3,700,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Aptinyx Inc.
| APTX | Common | 0 | -8,891,758 | 0 | -3,273,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Protagonist Therapeutics, Inc
| PTGX | Common | 0 | -2,260,572 | 0 | -19,057,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|